Yanqing Zhang
Harbin, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Comparison of the Efficacy Among Nilotinib, Dasatinib, Flumatinib and Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia Patients: A Real-World Multi-Center Retrospective Study.
Journal: Clinical lymphoma, myeloma & leukemia
Published: January 19, 2024
Competitive evolved sub-clonal BCR::ABL1 and novel MSI2::PC fusion genes in myelodysplastic syndrome with isolated del(5q).
Journal: Hematological oncology
Published: July 14, 2022
BCR-ABL1 is a secondary event after JAK2V617F in a patient with essential thrombocythemia who develop chronic myeloid leukemia.
Journal: Blood science (Baltimore, Md.)
Published: April 14, 2022
Prediction of the Prognosis Based on Chromosomal Instability-Related DNA Methylation Patterns of ELOVL2 and UBAC2 in PTCs.
Journal: Molecular therapy. Nucleic acids
Published: February 14, 2019
Combination of serum microRNAs and ultrasound profile as predictive biomarkers of diagnosis and prognosis for papillary thyroid microcarcinoma.
Journal: Oncology reports
Published: April 30, 2018
Dynamic monitoring of circulating microRNAs as a predictive biomarker for the diagnosis and recurrence of papillary thyroid carcinoma.
Journal: Oncology letters
Published: March 27, 2016
The synergistic antitumor activity of arsenic trioxide and vitamin K2 in HL-60 cells involves increased ROS generation and regulation of the ROS-dependent MAPK signaling pathway.
Journal: Die Pharmazie
Published: November 27, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026